State Street’s Atara Biotherapeutics ATRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$195K Hold
25,253
﹤0.01% 3844
2025
Q1
$150K Hold
25,253
﹤0.01% 3890
2024
Q4
$336K Buy
25,253
+2,900
+13% +$38.6K ﹤0.01% 3729
2024
Q3
$182K Buy
22,353
+7,680
+52% +$62.4K ﹤0.01% 3841
2024
Q2
$125K Sell
14,673
-84,889
-85% -$722K ﹤0.01% 3945
2024
Q1
$1.73M Sell
99,562
-11,806
-11% -$205K ﹤0.01% 3324
2023
Q4
$1.43M Buy
111,368
+10,461
+10% +$134K ﹤0.01% 3401
2023
Q3
$3.73M Sell
100,907
-775
-0.8% -$28.7K ﹤0.01% 3073
2023
Q2
$4.09M Sell
101,682
-227,817
-69% -$9.17M ﹤0.01% 3092
2023
Q1
$23.9M Buy
329,499
+23,509
+8% +$1.7M ﹤0.01% 2104
2022
Q4
$25.1M Sell
305,990
-17,904
-6% -$1.47M ﹤0.01% 2078
2022
Q3
$30.6M Buy
323,894
+75,027
+30% +$7.09M ﹤0.01% 1933
2022
Q2
$48.5M Sell
248,867
-2,078
-0.8% -$405K ﹤0.01% 1661
2022
Q1
$58.3M Buy
250,945
+77,977
+45% +$18.1M ﹤0.01% 1664
2021
Q4
$68.1M Buy
172,968
+21,732
+14% +$8.56M ﹤0.01% 1592
2021
Q3
$67.7M Sell
151,236
-23,638
-14% -$10.6M ﹤0.01% 1581
2021
Q2
$68M Sell
174,874
-1,637
-0.9% -$636K ﹤0.01% 1615
2021
Q1
$63.4M Buy
176,511
+57,133
+48% +$20.5M ﹤0.01% 1568
2020
Q4
$58.6M Sell
119,378
-9,864
-8% -$4.84M ﹤0.01% 1546
2020
Q3
$41.9M Sell
129,242
-1,392
-1% -$451K ﹤0.01% 1587
2020
Q2
$47.6M Buy
130,634
+40,806
+45% +$14.9M ﹤0.01% 1494
2020
Q1
$19.1M Buy
89,828
+1,809
+2% +$385K ﹤0.01% 1863
2019
Q4
$36.2M Sell
88,019
-16,232
-16% -$6.68M ﹤0.01% 1744
2019
Q3
$36.8M Buy
104,251
+11,625
+13% +$4.1M ﹤0.01% 1655
2019
Q2
$46.6M Buy
92,626
+24,865
+37% +$12.5M ﹤0.01% 1533
2019
Q1
$67.3M Buy
67,761
+372
+0.6% +$370K 0.01% 1269
2018
Q4
$58.5M Sell
67,389
-16,840
-20% -$14.6M 0.01% 1262
2018
Q3
$87.1M Buy
84,229
+209
+0.2% +$216K 0.01% 1161
2018
Q2
$77.2M Buy
84,020
+3,697
+5% +$3.4M 0.01% 1215
2018
Q1
$78.3M Buy
80,323
+62,570
+352% +$61M 0.01% 1138
2017
Q4
$8.03M Buy
17,753
+511
+3% +$231K ﹤0.01% 2562
2017
Q3
$7.14M Buy
17,242
+284
+2% +$118K ﹤0.01% 2608
2017
Q2
$5.94M Sell
16,958
-7,633
-31% -$2.67M ﹤0.01% 2658
2017
Q1
$12.6M Buy
24,591
+570
+2% +$293K ﹤0.01% 2243
2016
Q4
$8.53M Buy
24,021
+9,262
+63% +$3.29M ﹤0.01% 2422
2016
Q3
$7.89M Buy
14,759
+559
+4% +$299K ﹤0.01% 2312
2016
Q2
$8M Buy
14,200
+3,530
+33% +$1.99M ﹤0.01% 2340
2016
Q1
$5.08M Sell
10,670
-13,397
-56% -$6.37M ﹤0.01% 2536
2015
Q4
$15.9M Sell
24,067
-6,871
-22% -$4.54M ﹤0.01% 1881
2015
Q3
$24.3M Buy
30,938
+23,304
+305% +$18.3M ﹤0.01% 1631
2015
Q2
$10.1M Buy
7,634
+4,770
+167% +$6.29M ﹤0.01% 2257
2015
Q1
$2.97M Buy
2,864
+1,345
+89% +$1.4M ﹤0.01% 2851
2014
Q4
$1.02M Buy
+1,519
New +$1.02M ﹤0.01% 3258